FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Mervi Laakso

Research Profile

Genes & Molecular Sequences

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Gene Amplification

Phenomena

Color

Procedures

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Mervi Laakso; Minna Tanner; Jorma Isola
Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours.
Mervi Laakso; Minna Tanner; Jonas Nilsson; Tom Wiklund; Bjørn Erikstein; Pirkko Kellokumpu-Lehtinen; Per Malmström; Nils Wilking; Jonas Bergh; Jorma Isola
Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer.
Mervi Laakso; Niklas Loman; Ake Borg; Jorma Isola
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Mervi Laakso (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2006: Mervi Laakso; Minna Tanner; Jorma Isola
Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours.
The Journal of pathology 2006;210(1):3-9.
2006: Mervi Laakso; Minna Tanner; Jonas Nilsson; Tom Wiklund; Bjørn Erikstein; Pirkko Kellokumpu-Lehtinen; Per Malmström; Nils Wilking; Jonas Bergh; Jorma Isola
Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4185-91.
2005: Mervi Laakso; Niklas Loman; Ake Borg; Jorma Isola
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(10):1321-8.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.